Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BlueRock Therapeutics
Biotech
Bayer preps phase 2 after Parkinson's cell therapy scores win
The German pharma giant finally offered a deeper dive into phase 1 data that confirms Parkinson’s cell therapy bemdaneprocel hit its key endpoints.
James Waldron
Aug 28, 2023 2:00am
Bayer-owned BlueRock cuts 12% of staff as pipeline contracts
Aug 17, 2023 3:00pm
Bayer's acting BD chief lobbies for the job by making deals
May 24, 2023 3:00am
Bayer's BlueRock taps Rune Labs for Parkinson's study software
Mar 16, 2023 7:00am
Leaping forward: Bayer VC arm doubles investment pace with $1.4B
Apr 1, 2022 9:59am
Bayer's VC arm making 'Leaps' via 'fewer, but maybe bigger bets'
Jan 21, 2022 10:00am
